电热灸治疗常年性变应性鼻炎的随机对照预试验
本研究为随机、评估者盲的预试验,纳入40例常年性变应性鼻炎患者,比较电热灸与针刺的疗效与安全性。两组鼻症状总分和生活质量评分均较治疗前显著改善,组间无显著差异;针刺组瘙痒和喷嚏症状改善更明显,电热灸组未报告治疗相关不良事件,提示电热灸是安全替代疗法。
要点
- 电热灸可显著改善常年性变应性鼻炎患者的鼻症状总分和生活质量评分。
- 电热灸与针刺总体疗效无显著差异,针刺在瘙痒和喷嚏症状改善上更明显。
- 电热灸组未报告治疗相关不良事件,安全性较好。
核心结论
- 电热灸是常年性变应性鼻炎患者的一种安全替代治疗方法。
研究设计与样本
- 随机、评估者盲的预试验,纳入40例常年性变应性鼻炎患者,随机分为电热灸组和针刺组。
- 主要结局为治疗前后鼻症状总分(TNSS)变化,次要结局包括鼻结膜炎生活质量问卷(RQLQ)、鼻内镜辨证指数、变应性鼻炎辨证问卷、血清总IgE、嗜酸性粒细胞计数及不良事件。
主要发现
- 两组平均TNSS和RQLQ评分均较治疗前显著改善(p < 0.05),但组间无显著差异。
- 针刺组瘙痒和喷嚏TNSS平均变化显著高于电热灸组。
- 治疗前后血清总IgE和嗜酸性粒细胞计数无显著差异,两组三个证候亚组间TNSS平均变化无显著差异。
- 针刺组报告2例治疗相关不良事件,电热灸组无治疗相关不良事件。
临床怎么用
- 对于常年性变应性鼻炎患者,电热灸可作为安全的替代治疗选择。
- 电热灸在改善鼻症状和生活质量方面与针刺总体疗效相当,但针刺在瘙痒和喷嚏症状改善上可能更明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of allergic rhinitis (AR), an inflammatory disease, is gradually increasing. Studies have reported that moxibustion is effective for treating AR. Electric heating moxibustion (EM) was developed to offer adaptable heat stimulation without the generation of smoke. OBJECTIVES: The objective of this study was to examine the possibility of EM in treating perennial allergic rhinitis (PAR) and to assess the feasibility of using this technique on a larger scale by comparing EM with acupuncture (AC). DESIGN: A randomized pilot study was conducted on 40 patients with PAR. Patients were randomly assigned to one of two treatment groups: EM or AC. The primary outcome measure was the change in the total nasal symptom score (TNSS) between before and after treatment. The secondary outcome measures were the changes in the rhinoconjunctivitis quality of life questionnaire (RQLQ), nasal endoscopy index for pattern identification, pattern identification questionnaire for AR, total serum immunoglobulin E (IgE), eosinophil count, and adverse effects (AEs). RESULTS: The results showed a statistically significant improvement in mean TNSS and RQLQ scores in both groups (p < 0.05), but no significant difference between the two groups. However, mean changes in itching and sneezing TNSS were significantly higher in the AC group. There was no significant difference in total serum IgE or eosinophil count before versus after treatment, nor was there any significant difference of three pattern subgroups between the two groups in the mean TNSS change. While the AC group reported two treatment-related AEs, there were no treatment-related AEs in the EM group. CONCLUSION: This trial provides evidence that EM isa safe alternative treatment for patients with PAR. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03342105. Registered on 14 November 2017.
引用
- Jo HR, Sung WS, Jung CY, et al. Effectiveness and safety of electric heating moxibustion for perennial allergic rhinitis: A pilot, randomized, assessor-blind trial. Complement Ther Med. 2022. PMID: 35470006. doi:10.1016/j.ctim.2022.102835
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。